Wall Street Zen lowered shares of Stevanato Group (NYSE:STVN – Free Report) from a buy rating to a hold rating in a report published on Saturday.
Several other equities research analysts also recently weighed in on STVN. Morgan Stanley initiated coverage on Stevanato Group in a report on Monday, December 1st. They issued an “equal weight” rating and a $24.00 price target on the stock. Jefferies Financial Group set a $17.50 price objective on Stevanato Group in a research report on Tuesday. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Stevanato Group in a research report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.
Get Our Latest Research Report on Stevanato Group
Stevanato Group Stock Performance
Hedge Funds Weigh In On Stevanato Group
Institutional investors have recently made changes to their positions in the company. Farther Finance Advisors LLC purchased a new stake in Stevanato Group in the third quarter worth about $44,000. GW&K Investment Management LLC lifted its position in shares of Stevanato Group by 76.2% in the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after purchasing an additional 1,055 shares during the period. First Horizon Corp bought a new position in shares of Stevanato Group during the third quarter valued at approximately $50,000. State of Wyoming boosted its stake in shares of Stevanato Group by 39,216.7% during the second quarter. State of Wyoming now owns 2,359 shares of the company’s stock valued at $58,000 after purchasing an additional 2,353 shares in the last quarter. Finally, Quantbot Technologies LP purchased a new position in Stevanato Group during the third quarter valued at approximately $68,000.
About Stevanato Group
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Featured Articles
- Five stocks we like better than Stevanato Group
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
